 |
Press ReleasesSQI Diagnostics to Extend Warrant Expiry DateReleased: June 12, 2009 Toronto, Canada, June 12, 2009 - SQI Diagnostics Inc. (TSX-V: SQD), a medical systems automation company focused on evolving laboratory-based biomarker testing, announced today that it has received approval from the TSX Venture Exchange to extend the expiry date of 1,783,776 outstanding common share purchase warrants (the "Warrants") of the Corporation, which were issued in connection with the Corporation's June 2007 private placement financing. Each Warrant, as amended, entitles the holder thereof to purchase one common share of the Corporation at any time until the close of business on June 29, 2009 at an exercise price of $2.40 per common share. The Warrants will be amended, effective June 29, 2009, to extend the term of such Warrants until June 29, 2010. All other provisions of the Warrants will remain the same. There are two insiders of the Corporation who hold a total of 117,500 Warrants. About SQI Diagnostics For further information please contact:
Certain information in this press release is based on beliefs and assumptions of the Company's senior management and information currently available to it that may constitute forward-looking information within the meaning of securities laws. Such statements reflect the current views of the Company with respect to future events and are subject to certain risks and uncertainties. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. This release was prepared by management of the Company who takes full responsibility for its contents. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release. |
